Baker Bros. Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-104,161
| Closed | -$2.95M | – | 110 |
|
|
2018
Q2 | $2.95M | Sell |
104,161
-147,727
| -59% | -$4.18M | 0.02% | 93 |
|
|
2018
Q1 | $8.92M | Hold |
251,888
| – | – | 0.08% | 63 |
|
|
2017
Q4 | $9.77M | Hold |
251,888
| – | – | 0.08% | 58 |
|
|
2017
Q3 | $6.4M | Hold |
251,888
| – | – | 0.05% | 69 |
|
|
2017
Q2 | $6.88M | Hold |
251,888
| – | – | 0.06% | 56 |
|
|
2017
Q1 | $8.34M | Buy |
251,888
+50,000
| +25% | +$1.65M | 0.07% | 53 |
|
|
2016
Q4 | $4.81M | Buy |
+201,888
| New | +$4.81M | 0.05% | 65 |
|
|
2015
Q2 | – | Sell |
-35,719
| Closed | -$1.28M | – | 130 |
|
|
2015
Q1 | $1.28M | Sell |
35,719
-12,478
| -26% | -$445K | 0.01% | 116 |
|
|
2014
Q4 | $1.09M | Hold |
48,197
| – | – | 0.01% | 113 |
|
|
2014
Q3 | $935K | Hold |
48,197
| – | – | 0.01% | 97 |
|
|
2014
Q2 | $1.75M | Hold |
48,197
| – | – | 0.02% | 92 |
|
|
2014
Q1 | $1.87M | Sell |
48,197
-1,803
| -4% | -$70K | 0.02% | 89 |
|
|
2013
Q4 | $1.43M | Hold |
50,000
| – | – | 0.02% | 84 |
|
|
2013
Q3 | $1.79M | Buy |
+50,000
| New | +$1.79M | 0.03% | 72 |
|